A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of live or killed Lactobacillus sakei Probio65 on atopic dermatitis in children

Probionic0 个研究点目标入组 90 人开始时间: 待定最近更新: 2019年5月20日

适应症

试验速览

暂无简介。

•1) Those who agreed to participate in this test and presented a document, voluntarily signed by the subject, the parent, or legal representative
•2) Those who aged 3 to 18 years
•3) Those who have intermittent or persistent atopic dermatitis symptoms for more than 6 months
•4) Those who have SCORAD scores between 20 and 50 (mild-moderate)

•1) Those who have severe skin disease or systemic disease in addition to atopic dermatitis
•2) Those who administered antibiotics, corticosteroids, antihistamines, or immuno-suppressants within 4 weeks of screening
•3) Those who administered medicines, herbal medicine, or health functional foods to improve the symptom of atopic dermatitis within 4 weeks of screening
•4) Those who received phototherapy within 4 weeks of screening
•5) Those who have taken probiotics within 2 weeks of screening
•6) Those who plan to participate in other tests during this clinical trial
•7) Those who participated in other clinical trials within 4 weeks of the start of this clinical trial
•8) Those who considered as inappropriate for this clinical trial by the judgment of the tester

发起方

Probionic